About Us

Transforming Diabetes Care Together, For Greater Freedom And Better Health

For more than 30 years, Medtronic has been helping people with diabetes.

Medtronic is working with the global community to change the way people manage diabetes. Together, we will transform diabetes care by expanding access, integrating care and improving outcomes, so people with diabetes can enjoy greater freedom and better health.

Under the leadership of Hooman Hakami, Executive Vice President and President of the Diabetes Group, we operate three global business units to serve customers worldwide.

  • The Advanced Insulin Management (AIM) Business Unit: The AIM business unit is focused on serving patients in need of insulin pump therapy. This business unit will work to drive increased automation to our pump platform to maximize the time people are within a set target glucose range, and ultimately work to develop a fully automated, closed loop system.
  • The Multiple Daily Injection Solutions (MDIS) Business Unit: This business unit will deliver innovative solutions that address unmet needs for people with both type 1 and 2 diabetes who rely on multiple daily injections to manage their diabetes. This business will focus on empowering people with diabetes to achieve better outcomes with smart, connected solutions.
  • The Non-Intensive Diabetes Therapies (NDT) Business Unit: The NDT business unit is focused on addressing the needs of patients with type 2 diabetes who do not use intensive insulin regimens and provides solutions along the diabetes care continuum. The NDT team, working together with our partners, people with diabetes, providers, and payers, is focused on developing products and solutions that provide personalized therapy adjustments that may reduce glucose variability and improve A1C1,2,3,4,5.


Always By Your SideSM

Medtronic has supported over 1.2 million people living with diabetes around the world guided by our Always By Your Side promise.

Diabetes plays no favorites.
From the very young to the young at heart,
It’s a lifelong challenge.
There are no vacation days.
No holidays.
No days off.
Diabetes is ever present.
But you’re not alone.
We understand your journey.
Through education and outreach,
Product access and service,
And a global support team,
We strive to make life easier.
For people and their caregivers.
For physicians and HCP’s.
For everyone affected by this disease
Because we are all in this together.
Wherever you are, know that we are
Always By Your Side.

The Diabetes Group at Medtronic is part of Medtronic plc, the global leader in medical technology. We are proud of our long history of innovation and the Medtronic Mission, which continues to unite all of us worldwide in a higher purpose: to alleviate pain, restore health, and extend lives.

Hooman Hakami - Executive Vice President and President, Diabetes
Hooman Hakami

Executive Vice President and President, Diabetes

Hooman Hakami was named Executive Vice President and Group President of Medtronic Diabetes in June of 2014. Hooman provides overall strategic direction and operational management of the Group’s three global business units.

Hooman came to Medtronic after more than 20 years at General Electric. He was President and CEO of Detection & Guidance Solutions at GE Healthcare from April 2012 until May 2014. In that role he led that company’s business specializing in x-ray based technology solutions. Previously he served as President and CEO of the Interventional Systems business based in France, and the Global Clinical Systems Services for GE Healthcare.

Hooman received his Bachelor in Business Administration degree in operations management from the University of Massachusetts, where he graduated cum laude in 1991. Away from work he enjoys travel, sports, and spending time with his family.


  1. Mohan V, Jain S, Kesavadev J, et al. Use of retrospective continuous glucose monitoring for optimizing management of type 2 diabetes in India. Journal of The Association of Physicians of India, 2016. 64,16–21.
  2. Leinung M, Nardacci E, Patel N, Bettadahalli S, Paika K, Thompson S. Benefits of short-term professional continuous glucose monitoring in clinical practice. Diabetes Technology & Therapeutics. 2013;15(9):744-747.
  3. Allen N, Fain J, Braun B, Chipkin S. Continuous glucose monitoring counseling improves physical activity behaviors of individuals with type 2 diabetes: A randomized clinical trial. Diabetes Research and Clinical Practice. 2008;80(3):371-379.
  4. Kesavadev J, Vigersky R, Shin J et al. Assessing the therapeutic utility of professional continuous glucose monitoring in type 2 diabetes across various therapies: A retrospective evaluation. Advances in Therapy. 2017;34(8):1918-1927.
  5. Kim S, Kim H, Kim T et al. Effectiveness of 3-day continuous glucose monitoring for improving glucose control in type 2 diabetic patients in clinical practice. Diabetes & Metabolism Journal. 2014;38(6):449.